Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 37 min 36 sec ago

Antares Pharma Appoints James E. Fickenscher, Senior Vice President, Chief Financial Officer

Tue, 11/18/2014 - 19:00
EWING, N.J.--(Healthcare Sales & Marketing Network)--Antares Pharma, Inc. (ATRS) today announced the appointment of James E. Fickenscher to the position of Senior Vice President, Chief Financial Officer. Mr. Fickenscher has a diversified corporate backgrou...
Biopharmaceuticals, Personnel
Antares Pharma

First U.S. Procedures Completed With The Symphion(TM) Hysteroscopic Tissue Removal System

Mon, 11/17/2014 - 16:38
MARLBOROUGH, Mass., Nov. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporation (BSX) announces the completion of the first U.S. procedures performed with the Symphion System, designed for the hysteroscopic removal of interute...
Devices, Product Launch
Boston Scientific, Symphion, hysteroscope, hysteroscopic

Actavis Successfully Completes Durata Therapeutics, Inc. Tender Offer

Mon, 11/17/2014 - 16:09
DUBLIN, Nov. 17, 2014 -- (Healthcare Sales & Marketing Network) -- Actavis plc (ACT) today announced that it has successfully completed its tender offer to purchase all outstanding shares of Durata Therapeutics, Inc. (DRTX), an innovative pharmaceutical c...
Biopharmaceuticals, Mergers & Acquisitions
Actavis, Durata Therapeutics, DALVANCE, antibiotic

Bristol-Myers Squibb to Construct a New Large-Scale Biologics Manufacturing Facility in Cruiserath, Ireland

Fri, 11/14/2014 - 12:58
State-of-the-art facility will produce multiple therapies for the company’s growing biologics portfolio Significant investment builds on 50 years of company’s manufacturing history in Ireland 350 to 400 manufacturing jobs and about 1,000 construction...
Bristol-Myers Squibb

Integra LifeSciences Announces FDA Clearance and Controlled Market Release of Expandable Interbody System for Spinal Surgery

Thu, 11/13/2014 - 13:22
PLAINSBORO, N.J., Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Integra LifeSciences Holdings Corporation (IART) today announced the controlled market release of the Integra(R) Expandable Interbody System, in the United States. The system, whi...
Devices, Orthopaedic, Neurosurgery, FDA
Integra LifeSciences, Expandable Interbody System, spine surgery

Monteris Medical Announces $30 Million Equity Financing

Thu, 11/13/2014 - 13:16
PLYMOUTH, Minn., Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Monteris Medical Corporation (Monteris), a pioneer developer of minimally invasive laser systems for the ablation of pathologic brain lesions such as primary and metastatic tumors...
Devices, Neurosurgery, Venture Capital
Monteris Medical, NeuroBlate

Nuvo Research(R) reacquires Pennsaid(R) 2% rights to South America, Central America, South Africa and Israel

Thu, 11/13/2014 - 13:11
MISSISSAUGA, ON, Nov. 13, 2014 -- (Healthcare Sales & Marketing Network) - Nuvo Research Inc. (NRI.TO), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products, today announced that it has reacquired Pennsaid 2% mark...
Biopharmaceuticals, Distribution
Nuvo Research, Pennsaid 2%, diclofenac

Blueprint Medicines Secures $50 Million in Series C Financing

Wed, 11/12/2014 - 13:45
Proceeds to support continued advancement of highly selective kinase inhibitors to genomically defined cancers, including first-in-class FGFR4 and KIT Exon 17 inhibitors Investor syndicate includes leading public healthcare funds CAMBRIDGE, Mass., No...
Biopharmaceuticals, Oncology, Venture Capital
Blueprint Medicines

Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP)

Wed, 11/12/2014 - 13:40
CHESTNUT RIDGE, N.Y., Nov. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Par Pharmaceutical Companies, Inc. today announced that it has received approval for its New Drug Application (NDA) for Vasostrict™ (vasopressin injection, USP) 20 units/mL f...
Biopharmaceuticals, FDA
Par Pharmaceutical, Vasostrict, vasopressin

Beverly Huss Joins Surefire Medical Board of Directors

Wed, 11/12/2014 - 13:34
WESTMINSTER, Colo., Nov. 12, 2014 -- (Healthcare Sales & Marketing Network) -- The Board of Directors of Surefire Medical, Inc. today announced the appointment of Beverly Huss as a director of the company. Surefire Medical's novel infusion systems are de...
Devices, Interventional, Oncology, Drug Delivery, Personnel
Surefire Medical, embolization

Globus Medical Announces ALTERA(TM) Minimally Invasive Articulating Expandable Spacer

Wed, 11/12/2014 - 13:29
Featured at NASS Booth #1119 AUDUBON, Pa.--(Healthcare Sales & Marketing Network)--Globus Medical, Inc. (GMED), a leading musculoskeletal implant manufacturer, and the worldwide leader in expandable interbody technology, today announced the launch of AL...
Devices, Orthopaedic, Neurosurgery, Product Launch
Globus Medical, ALTERA , interbody fusion, spine surgery

BioCardia(R), Inc. Announces FDA Acceptance of Phase III Clinical Trial Protocol Studying Bone Marrow-Derived Cell Therapy for Heart Failure Patients

Tue, 11/11/2014 - 14:25
Company’s CardiAMP™ Therapy is First Cell Therapy for Heart Failure to be regulated by FDA PMA Pathway and First Cell Therapy/Companion Diagnostic to be Studied Together in a Phase III U.S. Trial SAN CARLOS, Calif.--(Healthcare Sales & Marketing Network...
Regenerative Medicine, Cardiology, FDA
BioCardia, CardiAMP

Titan Pharmaceuticals Appoints Two New Board Members

Tue, 11/11/2014 - 14:16
SOUTH SAN FRANCISCO, CA--(Healthcare Sales & Marketing Network) - Titan Pharmaceuticals, Inc. (OTCBB: TTNP) announced today that it has appointed life sciences industry veterans Joseph A. Akers and James McNab Jr. to its board of directors. Mr. Akers, a fo...
Biopharmaceuticals, Personnel
Titan Pharmaceuticals

St. Mary’s Health Care System Expands Cardiac Imaging with Toshiba MR

Tue, 11/11/2014 - 14:04
Vantage Titan 1.5T MR Delivers More Efficient Cardiac Exams TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--To build leadership in the region for cardiac care, St. Mary’s Health Care System installed two Vantage Titan™ 1.5T MR systems from Toshi...
Devices, Radiology
Toshiba America Medical Systems, Vantage Titan, MR, imaging

Zimmer Announces FDA Clearance of the Stand-alone Optio-C(R) Anterior Cervical System for use with Structural Allograft/Autograft

Mon, 11/10/2014 - 15:38
The Optio-C System is a next-generation, modular stand-alone cervical device that offers allograft/autograft and PEEK options and delivers the strength, stability and fusion potential of a traditional ACDF MINNEAPOLIS, Nov. 10, 2014 -- (Healthcare Sales...
Devices, Orthopaedic, Neurosurgery, FDA
Zimmer Spine, Optio-C, Anterior Cervical Plate, spine surgery

ImThera Medical, Inc. Receives FDA Approval for Pivotal Study for Obstructive Sleep Apnea Device

Mon, 11/10/2014 - 15:31
THN3 Study Will Expand the Clinical Evidence for this Novel Neurostimulation Therapy for Moderate to Severe Obstructive Sleep Apnea SAN DIEGO, Nov. 10, 2014 -- (Healthcare Sales & Marketing Network) -- ImThera Medical, Inc., a privately held global med...
Devices, FDA
ImThera Medical, THN3 Study, aura6000, obstructive sleep apnea

BSD Medical Names Medical Device Veteran Clint Carnell President and Chief Executive Officer

Mon, 11/10/2014 - 15:14
Brings Track Record of Proven Leadership and Commercial Success SALT LAKE CITY--(Healthcare Sales & Marketing Network)--BSD Medical Corporation (BSDM) (Company or BSD), a leading provider of medical systems that utilize heat therapy to treat cancer, tod...
Devices, Oncology, Personnel
BSD Medical, MicroThermX, hyperthermia

Southern Spine adds new Dual Lamina configuration to its StabiLink(R) “Ultimate MIS” Spinal Fixation System

Mon, 11/10/2014 - 15:08
MACON, Ga.--(Healthcare Sales & Marketing Network)--Southern Spine, LLC, an ISO 13485:2003 certified manufacturer of implants and instruments for spinal surgery, announced today that they have added the Dual Lamina configuration with Laminar-LockTM technol...
Devices, Orthopaedic, Neurosurgery, Product Launch
Southern Spine, Dual Lamina, StabiLink, Spinal Fixation

NeoTract, Inc. Announces CMS Reimbursement for Innovative Minimally Invasive Procedure for Enlarged Prostate

Mon, 11/10/2014 - 15:05
Category I CPT Codes Will Expand Patient Access to Novel Treatment for Common Condition that Significantly Impacts Quality of Life PLEASANTON, Calif.--(Healthcare Sales & Marketing Network)--NeoTract, Inc., a medical device company focused on addressing...
Devices, Urology, Reimbursement
NeoTract, UroLift, benign prostatic hyperplasia, BPH

Finding Medical Independent Sales Reps and Saving Money: RepFinder USA Updated for iOS 8

Fri, 11/07/2014 - 22:38
HSMN's Disruptive Alternative to Recruiting Medical Sales Reps Now Optimized for iPhone 6 and iPhone 6 Plus Available Now on the Apple App Store PHILADELPHIA - November 7, 2014 -- The Healthcare Sales & Marketing Network (HSMN) announced today that R...
Devices, Distribution
Independent Sales Rep

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong